A BENEFIT-HARM AND COST-EFFECTIVENESS ANALYSIS OF AZITHROMYCIN FOR THE PREVENTION OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE